Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Leukemia

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 39 articles:
HTML format
Text format



Single Articles


    September 2018

  1. Ivosidenib in IDH1-Mutated Acute Myeloid Leukemia.
    N Engl J Med. 2018;379:1186.
    PubMed     Text format    


  2. YUN S, Vincelette ND
    Ivosidenib in IDH1-Mutated Acute Myeloid Leukemia.
    N Engl J Med. 2018;379:1186.
    PubMed     Text format    


  3. SAHIN I
    Ivosidenib in IDH1-Mutated Acute Myeloid Leukemia.
    N Engl J Med. 2018;379:1186.
    PubMed     Text format    


  4. IYASERE CA, Takvorian RW, Simeone FJ, Siegele BJ, et al
    Case 28-2018: A 39-Year-Old Man with Epistaxis, Pain and Erythema of the Forearm, and Pancytopenia.
    N Engl J Med. 2018;379:1072-1081.
    PubMed     Text format    


  5. DUNCAVAGE EJ, Jacoby MA, Chang GS, Miller CA, et al
    Mutation Clearance after Transplantation for Myelodysplastic Syndrome.
    N Engl J Med. 2018;379:1028-1041.
    PubMed     Text format     Abstract available


  6. TIACCI E, Venanzi A, Ascani S, Marra A, et al
    High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML.
    N Engl J Med. 2018;379:981-984.
    PubMed     Text format    


    August 2018
  7. KATAOKA K, Ogawa S
    PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma.
    N Engl J Med. 2018;379:696.
    PubMed     Text format    


  8. ISHITSUKA K, Utsunomiya A, Ishida T
    PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma.
    N Engl J Med. 2018;379:695.
    PubMed     Text format    



  9. PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma.
    N Engl J Med. 2018;379:695-697.
    PubMed     Text format    


    July 2018
  10. KARLSSON S
    Tipping Clonal Hematopoiesis into Transformation.
    N Engl J Med. 2018;379:295-296.
    PubMed     Text format    


    June 2018
  11. MAUVIEUX L, Miguet L, Fornecker L
    Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
    N Engl J Med. 2018;378:2442-3.
    PubMed     Text format    


  12. ULRICH BC
    Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
    N Engl J Med. 2018;378:2442.
    PubMed     Text format    



  13. Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
    N Engl J Med. 2018;378:2442-2443.
    PubMed     Text format    


  14. DINARDO CD, Stein EM, de Botton S, Roboz GJ, et al
    Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
    N Engl J Med. 2018;378:2386-2398.
    PubMed     Text format     Abstract available


    May 2018
  15. COPUR MS, Gauchan D, Crockett D
    Venetoclax-Rituximab in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2018;378:2142-3.
    PubMed     Text format    


  16. FERHANOGLU B, Ozturk E, Ozbalak M
    Venetoclax-Rituximab in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2018;378:2141-2.
    PubMed     Text format    



  17. Venetoclax-Rituximab in Chronic Lymphocytic Leukemia.
    N Engl J Med. 2018;378:2141-2144.
    PubMed     Text format    


  18. RATNER L, Waldmann TA, Janakiram M, Brammer JE, et al
    Rapid Progression of Adult T-Cell Leukemia-Lymphoma after PD-1 Inhibitor Therapy.
    N Engl J Med. 2018;378:1947-1948.
    PubMed     Text format    


    April 2018
  19. KORONES DN
    The Long Ride Home.
    N Engl J Med. 2018;378:1569-1571.
    PubMed     Text format    



  20. More on Ofatumumab for TTP.
    N Engl J Med. 2018;378:1364-1365.
    PubMed     Text format    


    March 2018
  21. JONGEN-LAVRENCIC M, Grob T, Hanekamp D, Kavelaars FG, et al
    Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
    N Engl J Med. 2018;378:1189-1199.
    PubMed     Text format     Abstract available


  22. STEENSMA DP, Ebert BL
    Clonal Hematopoiesis after Induction Chemotherapy for Acute Myeloid Leukemia.
    N Engl J Med. 2018;378:1244-1245.
    PubMed     Text format    


  23. SEYMOUR JF, Kipps TJ, Eichhorst B, Hillmen P, et al
    Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.
    N Engl J Med. 2018;378:1107-1120.
    PubMed     Text format     Abstract available


    February 2018
  24. EL-JAWAHRI AR, Schaefer PW, El Khoury JB, Martinez-Lage M, et al
    Case 5-2018: A 63-Year-Old Man with Confusion after Stem-Cell Transplantation.
    N Engl J Med. 2018;378:659-669.
    PubMed     Text format    


  25. PARK JH, Riviere I, Gonen M, Wang X, et al
    Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.
    N Engl J Med. 2018;378:449-459.
    PubMed     Text format     Abstract available


  26. MAUDE SL, Laetsch TW, Buechner J, Rives S, et al
    Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
    N Engl J Med. 2018;378:439-448.
    PubMed     Text format     Abstract available


    January 2018
  27. HIBBERT KA, Shepard JO, Lane RJ, Azar MM, et al
    Case 1-2018. A 39-Year-Old Woman with Rapidly Progressive Respiratory Failure.
    N Engl J Med. 2018;378:182-190.
    PubMed     Text format    


    December 2017
  28. KORTE AKM, Vos JM
    Ecthyma Gangrenosum.
    N Engl J Med. 2017;377:e32.
    PubMed     Text format    


    November 2017
  29. SAHOO RK, Kumar L
    Midostaurin in FLT3-Mutated Acute Myeloid Leukemia.
    N Engl J Med. 2017;377:1901-2.
    PubMed     Text format    


  30. ESKAZAN AE
    Midostaurin in FLT3-Mutated Acute Myeloid Leukemia.
    N Engl J Med. 2017;377:1901.
    PubMed     Text format    



  31. Midostaurin in FLT3-Mutated Acute Myeloid Leukemia.
    N Engl J Med. 2017;377:1902.
    PubMed     Text format    


    October 2017
  32. ROSENBAUM L
    Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy.
    N Engl J Med. 2017;377:1313-1315.
    PubMed     Text format    


    August 2017
  33. BRAUN R, Holler E
    Acute Ocular Graft-versus-Host Disease.
    N Engl J Med. 2017;377:676.
    PubMed     Text format    


    June 2017
  34. STONE RM, Mandrekar SJ, Sanford BL, Laumann K, et al
    Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.
    N Engl J Med. 2017 Jun 23. doi: 10.1056/NEJMoa1614359.
    PubMed     Text format     Abstract available



  35. Blinatumomab for Acute Lymphoblastic Leukemia.
    N Engl J Med. 2017;376:e49.
    PubMed     Text format    



  36. Blinatumomab for Acute Lymphoblastic Leukemia.
    N Engl J Med. 2017;376:e49.
    PubMed     Text format    


  37. SPIVAK JL
    Myeloproliferative Neoplasms.
    N Engl J Med. 2017;376:2168-2181.
    PubMed     Text format    


    May 2017
  38. GORDON SW, Krystal GW
    Auer Rods.
    N Engl J Med. 2017;376:2065.
    PubMed     Text format    


    April 2017
  39. GREMBECKA J, Cierpicki T
    Stabilizing the Mixed Lineage Leukemia Protein.
    N Engl J Med. 2017;376:1688-1689.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: